Periotherapia ^None

Periotherapia is a pharmaceutical company that focuses on developing a treatment for triple negative breast cancer. They aim to selectively inhibit ASV involved in pathogenesis without affecting physiological ASV in chronic diseases such as cancer, heart failure, arteriosclerosis, renal failure, and diabetic retinopathy.